![Gary Patou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Patou
Directeur/Membre du Conseil chez
XENON PHARMACEUTICALS INC.
Fortune : 2 M $ au 31/05/2026
Profil
Gary Patou currently works at Xenon Pharmaceuticals, Inc., as Independent Director from 2004, Scleroderma Research Foundation, as Advisor from 2021, and Star Therapeutics, Inc., as Chief Medical Officer from 2020.
Dr. Patou also formerly worked at Cerimon Pharmaceuticals, Inc., as President & Chief Executive Officer from 2008 to 2009, Ligand UK Ltd., as Director in 1995, GSK Plc, as Senior VP, Director-Project & Portfolio Management from 1995 to 2000, Smithkline Beecham Pharmaceuticals Ltd., as Senior VP, Director-Project & Portfolio Management from 1995 to 2000, Biointervene, Inc., as Director & Chief Medical Officer, Oscient Pharmaceuticals Corp., as Chief Medical Officer & Executive Vice President from 2004 to 2005, Genesoft Pharmaceuticals, Inc., as President in 2004, Peplin Ltd., as Chief Medical Officer in 2007, Cerimon Pharmaceuticals, Inc., as Chief Medical Officer from 2005 to 2006, Chiasma, Inc., as Senior Medical Advisor, MPM BioImpact LLC, as Advisor from 2020 to 2022, Pacira Biosciences, Inc., as Chief Medical Officer from 2009 to 2015, True North Therapeutics, Inc., as Chief Medical Officer from 2016 to 2017, and Blade Therapeutics, Inc., as Chief Medical Officer from 2018 to 2020.
Dr. Patou received his undergraduate degree, graduate degree, and doctorate degree from the University of London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 34 689 ( 0,04% ) | 2 M $ | 31/05/2026 |
Postes actifs de Gary Patou
| Sociétés | Poste | Début |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 01/01/2004 |
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies | Directeur Technique/Scientifique/R&D | 01/08/2020 |
Scleroderma Research Foundation
 Scleroderma Research Foundation BiotechnologyHealth Technology Engages in medical research to discover treatments for scleroderma | Consultant / Advisor | 01/01/2021 |
Anciens postes connus de Gary Patou
| Sociétés | Poste | Fin |
|---|---|---|
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Consultant / Advisor | 30/07/2022 |
| CHIASMA, INC. | Directeur Technique/Scientifique/R&D | 01/12/2020 |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Directeur Technique/Scientifique/R&D | 01/12/2020 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Directeur Technique/Scientifique/R&D | 01/06/2017 |
| PACIRA BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 19/08/2015 |
Formation de Gary Patou
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Commercial Services |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Genesoft Pharmaceuticals, Inc.
 Genesoft Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops anti-infective products | Commercial Services |
Peplin Ltd.
 Peplin Ltd. Pharmaceuticals: OtherHealth Technology Develops human therapeutic products for the treatment of cancer | Health Technology |
Cerimon Pharmaceuticals, Inc.
 Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and distributes biopharmaceutical products | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scleroderma Research Foundation
Scleroderma Research Foundation BiotechnologyHealth Technology Engages in medical research to discover treatments for scleroderma | Health Technology |
Smithkline Beecham Pharmaceuticals Ltd. | |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Health Technology |
Biointervene, Inc.
 Biointervene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies | Health Technology |
